On September 8, V&C Biotec presented the results of the project "Production of therapeutic secretome from scaled-up mesenchymal stem cell culture for clinical dermatological applications", following its successful completion. This milestone was made possible by the support of ProInnóvate and the collaboration of our strategic partners: GenLab, Unilabs, BTS and UTEC. With this project, we reaffirm our commitment to turning biotechnology into clinical solutions with real impact

At V&C Biotec we had the pleasure of welcoming Dr. Claudia Altamirano Gómez, full professor at the School of Biochemical Engineering of the Pontificia Universidad Católica de Valparaíso (Chile), recognized for her career in metabolic engineering and animal cell culture. During her visit, Dr. Altamirano shared valuable perspectives on the development of biotechnological processes based on cell culture, with applications in the production of biopharmaceuticals, nutraceuticals a

We are pleased to announce that, as of July 1, V&C Biotec has renewed its membership in the International Society for Cell & Gene Therapy (ISCT), a global network of more than 2,400 professionals dedicated to the development and application of cell and gene therapies (CGT), including some of the most influential thought leaders in the field today. Since 1992, ISCT has worked to advance these therapies through a focus on evidence-based translational value, bringing together ex

The president of the Sociedad Peruana de Inmunología (SPI), Liz Eliana Veramendi Espinoza, and the director of V&C Biotec S.A.C., Emilio Leopoldo Valdez Castañeda, have signed a cooperation agreement to promote collaborative research in immunology and biotechnology. This joint step reaffirms our commitment to research and opens new perspectives for scientific development in the country. By combining our capabilities and aligning our visions, we aim to advance cutting-edge res

In September 2022, V&C Biotec donated a kit valued at US$ 23,000 to the Instituto Nacional de Salud del Niño – San Borja (INSN-SB) to support a haploidentical hematopoietic progenitor cell transplant in a pediatric patient with acute leukemia. The kit included the reagents and consumables required for the magnetic cell separation process used in this type of transplant, in which V&C Biotec specialists perform T-cell depletion of the graft before it is infused into the patient

The V&C Biotec team took part in a three-week technical training placement in advanced cell therapy at leading centers in Navarra, Madrid and Barcelona. The placement was supported by Peru's National Innovation Program for Competitiveness and Productivity (Innóvate Perú). At V&C Biotec we develop advanced cell therapies with the aim of expanding the treatment options available to patients in Peru. #terapiasinnovadoras

On April 28, the First International Symposium on Cell Therapy, "State of the Art in Hematopoietic Progenitor Cell Transplantation," was held with the participation of Dr. Felipe Prósper (Clínica Universidad de Navarra, Spain), Dr. Manel Juan (Hospital Clínic, Spain), Dr. Antonio Pérez-Martínez (Hospital Universitario La Paz, Spain), Dr. Francisco Espinoza (Cells for Cells, Chile) and Dr. Maroun Khoury (International Society for Cell & Gene Therapy, LATAM), who shared their e